STOCK TITAN

Commodore Capital discloses 5.1% stake in PepGen (PEPG)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

PepGen Inc. ownership disclosure: Commodore Capital LP and related filers report beneficial ownership of 3,544,101 shares of common stock, representing 5.1% of the class. The filing is a Schedule 13G reporting holdings as of 03/04/2026, based on 69,115,292 shares outstanding as of February 26, 2026.

The report states the Firm is investment manager to Commodore Capital Master LP and that Michael Kramarz and Robert Egen Atkinson exercise investment discretion for the aggregated position.

Positive

  • None.

Negative

  • None.

Insights

Passive 13G filing shows a >5% stake disclosed by Commodore Capital.

Commodore Capital LP and affiliated filers disclosed beneficial ownership of 3,544,101 shares or 5.1% as of 03/04/2026. The filing is on Schedule 13G, which typically indicates a passive investment intent rather than an activist approach.

Control and voting are reported as shared; subsequent filings could show changes if the firm adopts an active strategy or exceeds disclosure thresholds requiring different SEC treatment.

Position size is material relative to outstanding shares but below common takeover thresholds.

The disclosed position equals 3,544,101 shares against 69,115,292 shares outstanding (as of 02/26/2026), giving a 5.1% stake. Reported powers are shared voting and shared dispositive power.

Cash‑flow treatment and any trading intent are not stated in the excerpt; future filings would disclose any active changes to holdings or voting intentions.






03/04/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:03/11/2026
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:03/11/2026
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:03/11/2026
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:03/11/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement

FAQ

What stake did Commodore Capital report in PepGen (PEPG)?

They reported beneficial ownership of 3,544,101 shares, equal to 5.1% of PepGen's common stock. This percentage is based on 69,115,292 shares outstanding reported as of 02/26/2026 in the company's Form 10-K.

What filing did Commodore Capital use to disclose its PepGen holding?

Commodore Capital filed a Schedule 13G, indicating a passive reporting category for the position. The Schedule 13G in the excerpt lists ownership as of 03/04/2026 and names related filers and addresses.

Who within Commodore exercises investment discretion over the PepGen shares?

The filing names Michael Kramarz and Robert Egen Atkinson as managing partners who exercise investment discretion. The Firm is identified as investment manager to Commodore Capital Master LP in the disclosure.

Are the voting and dispositive powers sole or shared for this PepGen stake?

The report shows shared voting power and shared dispositive power for 3,544,101 shares. Sole voting and dispositive powers are reported as 0.00 for the filers in the excerpt.

What outstanding share count was used to calculate the 5.1% figure for PEPG?

The 5.1% ownership percentage is calculated using 69,115,292 shares outstanding as reported in PepGen's Form 10-K dated 02/26/2026, per the filing's stated reference.
PepGen Inc

NASDAQ:PEPG

View PEPG Stock Overview

PEPG Rankings

PEPG Latest News

PEPG Latest SEC Filings

PEPG Stock Data

425.06M
67.80M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON